GOLDMAN SACHS GROUP INC - CAPRICOR THERAPEUTICS INC ownership

CAPRICOR THERAPEUTICS INC's ticker is CAPR and the CUSIP is 14070B309. A total of 32 filers reported holding CAPRICOR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CAPRICOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$83,958
-28.5%
24,5490.0%0.00%
Q2 2023$117,344
+12.9%
24,549
-0.3%
0.00%
Q1 2023$103,913
+9.5%
24,624
+0.1%
0.00%
Q4 2022$94,933
-36.7%
24,594
-1.5%
0.00%
Q3 2022$150,000
+72.4%
24,964
+0.1%
0.00%
Q2 2022$87,000
-40.0%
24,949
-40.9%
0.00%
Q1 2022$145,000
+62.9%
42,238
+38.9%
0.00%
Q4 2021$89,0000.0%30,417
+37.4%
0.00%
Q3 2021$89,000
-50.3%
22,138
-43.0%
0.00%
Q2 2020$179,00038,8080.00%
Other shareholders
CAPRICOR THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Coastal Bridge Advisors, LLC 10,894$52,0730.01%
GSA CAPITAL PARTNERS LLP 17,890$860.01%
Tower Research Capital LLC (TRC) 12,236$58,4880.00%
Cutler Group LLC / CA 1,700$80.00%
VANGUARD GROUP INC 1,146,718$5,481,3120.00%
JANE STREET GROUP, LLC 13,260$63,3830.00%
Belvedere Trading LLC 2,000$9,5600.00%
Belvedere Trading LLC 8,053$38,4930.00%
OSAIC HOLDINGS, INC. 6,000$28,6800.00%
DIMENSIONAL FUND ADVISORS LP 24,085$115,1260.00%
View complete list of CAPRICOR THERAPEUTICS INC shareholders